Press Releases
Alpha Szenszor Inc. and Technion Announce Joint Venture in Lung Cancer Diagnostics
Alpha Szenszor Inc., a leading provider of carbon nanotube based sensors and the Technion -Israel Institute of Technology have announced a joint venture for the commercialization of advanced lung cancer diagnostics based on Volatile Organic Compound (VOC) detection...
Press Releases
GE Healthcare Works to Speed Up Fight Against Cancer
GE Healthcare’s work to accelerate cancer innovation and improve care for cancer patients reached new milestones in advanced technology. The campaign is founded on GE Healthcare’s integrated portfolio, which is uniquely positioned to drive...
Press Releases
Rhenovia Pharma recognized as the world leader in biosimulation of the central nervous system
Rhenovia Pharma, a biotechnology company created in 2007, today announces it has had its position confirmed as world leader in the field of biosimulation for research into drugs for treating diseases of the central nervous system. ...
Press Releases
Cerulean Announces First Patient Dosed in Randomized Phase 2 Study of CRLX101 in Advanced Small Cell Lung Cancer
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer...
Press Releases
FDA Advisory Committee Recommends Approval for Boehringer Ingelheim’s Olodaterol* for Maintenance Treatment of COPD
Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommended that clinical data included in a new drug application (NDA) provide substantial and convincing evidence to support the approval of...
Press Releases
Regional Cancer Care Associates Expands Footprint in New Jersey
Regional Cancer Care Associates (RCCA), New Jersey’s largest oncology physician network and one of the largest in the nation, is pleased to announce that three practices have joined its growing network, which now includes 92 cancer care specialists...
Press Releases
Direct Flow Medical Receives CE Mark for Transcatheter Aortic Heart Valve System That Virtually Eliminates Aortic Regurgitation
Direct Flow Medical, Inc., a transcatheter heart valve innovator focused on improving patient outcomes, announced that it has received CE Mark (Conformité Européenne) for its distinctive transcatheter aortic heart valve with a metal-free frame and low-profile transfemoral delivery...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read